BOSTON, MA and PARIS--(Marketwire - January 26, 2010) - KIKA™ Clinical Solutions announced record-breaking growth in 2009, with service bookings up by 97% over 2008. KIKA is the leading provider of advanced EDC solutions for Clinical Asset Management™ for the pharmaceutical, biotechnology and medical device markets.
KIKA was awarded 28 new trials from new and existing customers in therapeutic areas including electrophysiology, interventional cardiology, cardiovascular; interventional radiology; neuroradiology; oncology; orthopedics; thoracic/vascular surgery; and, urology. Significantly, 57% of bookings came from existing customers who have used KIKA's EDC system successfully on previous trials.
KIKA CEO Linda Beneze said, "Our tremendous growth in 2009 was based on a number of factors. Existing customers conducted multiple clinical trials with Veracity™ because it delivers a reliable, advanced EDC solution with extremely robust reporting tools enabling sponsors to track the progress of their trial like no other solution on the market. Additionally, our online adjudication capabilities continue to differentiate KIKA from others in the market. With the ability to have images imbedded into the patient record, CEC members can efficiently make decisions about the cause of adverse events."
Additional 2009 KIKA highlights included:
Veracity™ 3.7, New Version of Advanced EDC Solution for Clinical Trial Management
KIKA announced a new version of Veracity™, the only Web-based software platform for collecting, analyzing and managing clinical trial data. Veracity™ is a highly configurable, collaborative platform. It enables all clinical trial stakeholders to collect, monitor, adjudicate, analyze and manage clinical study data in real time and store them into a CDISC-ready database. Veracity™'s imaging capabilities replace outmoded, inaccurate and slow methods such as courier services or FTP sites. Additionally, Veracity™ is supported by an ISO-certified quality environment. It enables regulatory compliance including 21 CFR Part 11. Veracity™ is part of KIKA's three-part approach to eClinical trials which includes world-class services, and the industry's most reliable IT infrastructure, with less than one hour of unscheduled downtime in 11 years.
Inaugural U.S. and European User Group Meetings
Representatives of pharmaceutical, life sciences and medical device companies convened to discuss clinical trial management innovations and trends at KIKA's first User Group Meetings in Boston, Mass. and Chantilly, France. One customer who spoke cited a 90 percent compliance rate at the six-month follow up on a clinical trial with 15,175 patients at 320 sites in 56 countries. Another sponsor conducting an 8,000 patient study explained how KIKA's EDC solutions offer substantial value at the back end and helped reduce monitoring site visits by an estimated 75 percent.
KIKA Partnership Program Expansion
KIKA's unique Web services architecture enables the company to integrate its Clinical Asset Management™ solution with partners' offerings very easily. KIKA's Partner Program provides customers with best-in-breed technologies and services, all integrated in to KIKA's platform. KIKA signed ten partners in the areas of Technology and Service; CROs (Contract Research Organizations); and, Co-Marketing. Current KIKA partners provide technologies including randomization, coding, CTMS and ePRO.
Thought Leadership and Education
KIKA executives participated in top industry conferences in the U.S. and internationally, including: DIA conferences; 18th Annual Partnerships with CROs; the Medical Device Clinical Congress (MDCC); Waife & Associates 12th Annual Executive Retreat on Clinical Operations; the CDISC English Speaking User Group (ESUG) Teleconference on "HL7 and the Link to CDISC;" the DIA 45th Annual Meeting; and Cambridge Health Tech Institute's Inaugural Electronic Data in Clinical Trials Conference.
About KIKA Clinical Solutions
KIKA helps the world's most innovative biopharmaceutical and medical device organizations use advanced EDC solutions to bring much-needed medical solutions to market faster. KIKA's Veracity™ is the leading-edge Web-based clinical trial software platform that delivers Clinical Asset Management™ for any size clinical trial. Veracity is customized to meet study needs precisely. It provides unmatched flexibility and customization with advanced EDC including images and online adjudication. Veracity is backed by the industry's most reliable IT infrastructure and a world class Professional Services organization. For more information, visit www.kikaclinicalsolutions.com.
KIKA, Veracity and Clinical Asset Management are trademarks of the KIKA
group of companies.
Digg this
Bookmark with del.icio.us
Add to Newsvine
Technorati:
